Skip to main content Skip to section navigation Skip to footer
  • Visit us on Facebook
  • Visit us on Twitter
  • Visit us on Linkedin
Kintara Therapeutics, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaboration
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News & Events
    • Company Info
    • Stock Info
    • SEC Filings
    • Governance
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update

September 18, 2023 • 4:25 PM EDT

Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting

September 5, 2023 • 8:00 AM EDT

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023

August 17, 2023 • 5:26 PM EDT

Kintara Therapeutics to Present at the Emerging Growth Conference

August 9, 2023 • 8:16 AM EDT

Kintara Therapeutics to Participate in the Fifth Annual Glioblastoma Awareness Day in Washington, D.C.

July 19, 2023 • 8:00 AM EDT

Kintara Therapeutics Awarded $2.0 Million National Institutes of Health SBIR Grant to Support the Clinical Development of REM-001

June 28, 2023 • 4:15 PM EDT

Kintara Therapeutics to Participate in the Maxim Group Virtual Healthcare Conference

June 16, 2023 • 8:00 AM EDT

Kintara Therapeutics to Commemorate National Brain Tumor Awareness Month with Ringing the Bell at Nasdaq Closing Along with Global Coalition for Adaptive Research and the National Brain Tumor Society

May 19, 2023 • 8:30 AM EDT

Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update

May 11, 2023 • 8:15 AM EDT

Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference

May 8, 2023 • 8:30 AM EDT
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 35
  • Next Pagearrow_forward
rss_feed News RSS
©2023 Kintara Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences